Accueil   Diary - News   All news Focus on Cellipse

Focus on Cellipse


Cellipse is a company member of Lyonbiopole based in Grenoble. It was created in early 2013 by three co- founders: Dr. Laurence Lafanechère , Dr Renaud Prudent and Fabrice Paublant . They rely on internal know- how in the high content phenotypic screening and optimizing small molecule lead. The co- founders of CELLIPSE are trying to build a company Biotech leader in the field of small agents cytoskeletal regulatory molecules with application in oncology and beyond ( Central Nervous System , Eyesight ... ) . CELLIPSE and Albert Bonniot Institute , Grenoble won the Proof of Concept Competition 2013 Cancéropôle CLARA .



Cellipse just joined the Board of Directors of the pole for 2 years , as a non-permanent member and representative of the business college. This SME Drug Discovery aims to bring innovative therapies to patients with cancer. She develops a portfolio of small molecules targeting the cytoskeleton ( microtubules and actin ) based on its approach "cell to drug discovery ." It will be part of the Rhône-Alpes Lyonbiopôle delegation that will accompany BIO San Diego from 23 to 26 June.





By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to More details are available by clicking here I agree